LivaNova PLC (LIVN)
USD 37.48
(-5.11%)
USD 37.48
(-5.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 843.54 Million USD | 4.89% |
| 2022 | 654.5 Million USD | -7.4% |
| 2021 | 706.8 Million USD | 6.9% |
| 2020 | 661.2 Million USD | -5.11% |
| 2019 | 696.8 Million USD | 7.5% |
| 2018 | 648.2 Million USD | 23.84% |
| 2017 | 523.4 Million USD | -17.86% |
| 2016 | 637.2 Million USD | 281.78% |
| 2015 | 166.9 Million USD | -0.18% |
| 2014 | 167.2 Million USD | 8.53% |
| 2013 | 154.06 Million USD | 11.72% |
| 2012 | 137.9 Million USD | 16.61% |
| 2011 | 118.25 Million USD | 7.5% |
| 2010 | 110 Million USD | 5.2% |
| 2009 | 104.57 Million USD | -3.5% |
| 2008 | 108.36 Million USD | -33.2% |
| 2007 | 162.23 Million USD | -2.77% |
| 2006 | 166.85 Million USD | 65.57% |
| 2005 | 100.77 Million USD | 14.86% |
| 2004 | 87.73 Million USD | 4.79% |
| 2003 | 83.71 Million USD | 0.01% |
| 2002 | 83.7 Million USD | 0.0% |
| 2000 | 42.75 Million USD | 13.11% |
| 1999 | 37.8 Million USD | 35.48% |
| 1998 | 27.9 Million USD | 119.69% |
| 1997 | 12.7 Million USD | 9.48% |
| 1996 | 11.6 Million USD | 30.34% |
| 1995 | 8.9 Million USD | 25.35% |
| 1994 | 7.1 Million USD | 24.56% |
| 1993 | 5.7 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 171.72 Million USD | -4.33% |
| 2024 Q2 | 173.85 Million USD | 1.24% |
| 2024 Q3 | 189.64 Million USD | 9.08% |
| 2023 Q2 | 187.8 Million USD | 6.46% |
| 2023 Q3 | 197.3 Million USD | 5.06% |
| 2023 FY | 686.49 Million USD | 4.89% |
| 2023 Q4 | 179.5 Million USD | -9.02% |
| 2023 Q1 | 176.4 Million USD | 4.07% |
| 2022 FY | 654.5 Million USD | -7.4% |
| 2022 Q4 | 169.5 Million USD | -2.3% |
| 2022 Q3 | 173.49 Million USD | 13.69% |
| 2022 Q2 | 152.6 Million USD | -3.99% |
| 2022 Q1 | 158.93 Million USD | -10.15% |
| 2021 Q1 | 163.94 Million USD | -20.42% |
| 2021 Q2 | 208.54 Million USD | 27.2% |
| 2021 Q3 | 152.24 Million USD | -27.0% |
| 2021 Q4 | 176.9 Million USD | 16.2% |
| 2021 FY | 706.8 Million USD | 6.9% |
| 2020 Q3 | 156.25 Million USD | 17.84% |
| 2020 FY | 661.2 Million USD | -5.11% |
| 2020 Q2 | 132.59 Million USD | -20.32% |
| 2020 Q1 | 166.4 Million USD | -0.48% |
| 2020 Q4 | 206 Million USD | 31.84% |
| 2019 Q1 | 178.59 Million USD | 5.74% |
| 2019 Q2 | 170.98 Million USD | -4.26% |
| 2019 Q4 | 167.2 Million USD | -7.14% |
| 2019 Q3 | 180.06 Million USD | 5.31% |
| 2019 FY | 696.8 Million USD | 7.5% |
| 2018 Q1 | 144.8 Million USD | 1.54% |
| 2018 Q3 | 167.01 Million USD | -0.23% |
| 2018 Q4 | 168.9 Million USD | 1.13% |
| 2018 Q2 | 167.4 Million USD | 15.61% |
| 2018 FY | 648.2 Million USD | 23.84% |
| 2017 Q4 | 142.6 Million USD | -13.53% |
| 2017 FY | 523.4 Million USD | -17.86% |
| 2017 Q3 | 164.92 Million USD | -5.79% |
| 2017 Q2 | 175.05 Million USD | 14.07% |
| 2017 Q1 | 153.46 Million USD | -6.14% |
| 2016 Q4 | 163.5 Million USD | 7.92% |
| 2016 Q3 | 151.5 Million USD | -3.32% |
| 2016 FY | 637.2 Million USD | 281.78% |
| 2016 Q2 | 156.7 Million USD | -3.98% |
| 2016 Q1 | 163.2 Million USD | 0.0% |
| 2015 Q3 | 56.43 Million USD | 28.94% |
| 2015 FY | 166.9 Million USD | -0.18% |
| 2015 Q2 | 43.76 Million USD | 4.73% |
| 2015 Q1 | 41.78 Million USD | -0.17% |
| 2014 Q1 | 44 Million USD | 8.31% |
| 2014 Q2 | 43.59 Million USD | -0.95% |
| 2014 Q4 | 41.85 Million USD | 3.64% |
| 2014 Q3 | 40.38 Million USD | -7.34% |
| 2014 FY | 167.2 Million USD | 8.53% |
| 2013 Q3 | 41.28 Million USD | 0.01% |
| 2013 Q4 | 40.62 Million USD | -1.59% |
| 2013 Q1 | 41.52 Million USD | 12.55% |
| 2013 FY | 154.06 Million USD | 11.72% |
| 2013 Q2 | 41.28 Million USD | -0.58% |
| 2012 Q3 | 37.61 Million USD | -1.13% |
| 2012 Q1 | 35.16 Million USD | 3.31% |
| 2012 FY | 137.9 Million USD | 16.61% |
| 2012 Q4 | 36.89 Million USD | -1.92% |
| 2012 Q2 | 38.04 Million USD | 8.18% |
| 2011 Q3 | 34.46 Million USD | 0.69% |
| 2011 FY | 118.25 Million USD | 7.5% |
| 2011 Q4 | 34.03 Million USD | -1.24% |
| 2011 Q2 | 34.22 Million USD | 7.33% |
| 2011 Q1 | 31.89 Million USD | 7.85% |
| 2010 Q2 | 27.64 Million USD | -7.86% |
| 2010 Q1 | 30 Million USD | 11.79% |
| 2010 FY | 110 Million USD | 5.2% |
| 2010 Q3 | 29.14 Million USD | 5.43% |
| 2010 Q4 | 29.57 Million USD | 1.47% |
| 2009 Q1 | 26.75 Million USD | 5.58% |
| 2009 Q4 | 26.83 Million USD | 1.21% |
| 2009 FY | 104.57 Million USD | -3.5% |
| 2009 Q3 | 26.51 Million USD | -0.49% |
| 2009 Q2 | 26.64 Million USD | -0.4% |
| 2008 FY | 108.36 Million USD | -33.2% |
| 2008 Q2 | 26.13 Million USD | 4.64% |
| 2008 Q4 | 25.34 Million USD | -3.78% |
| 2008 Q1 | 24.97 Million USD | 4.14% |
| 2008 Q3 | 26.33 Million USD | 0.78% |
| 2007 Q2 | 31.43 Million USD | -12.46% |
| 2007 Q1 | 35.9 Million USD | -20.91% |
| 2007 Q3 | 27.97 Million USD | -10.99% |
| 2007 Q4 | 23.98 Million USD | -14.29% |
| 2007 FY | 162.23 Million USD | -2.77% |
| 2006 Q1 | 34.87 Million USD | -17.03% |
| 2006 Q4 | 45.39 Million USD | 6.58% |
| 2006 Q3 | 42.59 Million USD | 11.09% |
| 2006 FY | 166.85 Million USD | 65.57% |
| 2006 Q2 | 38.33 Million USD | 9.94% |
| 2005 FY | 100.77 Million USD | 14.86% |
| 2005 Q4 | 42.03 Million USD | -11.84% |
| 2005 Q3 | 47.67 Million USD | 12.79% |
| 2005 Q2 | 42.27 Million USD | 40.37% |
| 2005 Q1 | 30.11 Million USD | 28.15% |
| 2004 Q1 | 23.56 Million USD | 2155.72% |
| 2004 Q2 | 23.36 Million USD | -0.87% |
| 2004 Q3 | 23.79 Million USD | 1.85% |
| 2004 FY | 87.73 Million USD | 4.79% |
| 2004 Q4 | 23.49 Million USD | -1.25% |
| 2003 Q2 | 20.06 Million USD | 2.42% |
| 2003 Q4 | 1.04 Million USD | -95.04% |
| 2003 FY | 83.71 Million USD | 0.01% |
| 2003 Q1 | 19.58 Million USD | -1.16% |
| 2003 Q3 | 21.06 Million USD | 5.01% |
| 2002 Q3 | 21.16 Million USD | -8.59% |
| 2002 Q4 | 19.81 Million USD | -6.37% |
| 2002 FY | 83.7 Million USD | 0.0% |
| 2002 Q2 | 23.15 Million USD | -3.07% |
| 2002 Q1 | 23.88 Million USD | 16.16% |
| 2001 Q3 | 20.58 Million USD | 10.23% |
| 2001 Q2 | 18.67 Million USD | 23.37% |
| 2001 Q4 | 20.56 Million USD | -0.12% |
| 2001 Q1 | 15.13 Million USD | -1.88% |
| 2000 Q2 | 13.37 Million USD | 16.76% |
| 2000 Q1 | 11.45 Million USD | 23.19% |
| 2000 FY | 42.75 Million USD | 13.11% |
| 2000 Q4 | 15.42 Million USD | 10.67% |
| 2000 Q3 | 13.94 Million USD | 4.22% |
| 1999 Q2 | 8.7 Million USD | -11.22% |
| 1999 Q1 | 9.8 Million USD | 0.0% |
| 1999 Q3 | 8.6 Million USD | -1.15% |
| 1999 Q4 | 9.3 Million USD | 8.14% |
| 1999 FY | 37.8 Million USD | 35.48% |
| 1998 FY | 27.9 Million USD | 119.69% |
| 1998 Q4 | 9.8 Million USD | 3.16% |
| 1998 Q3 | 9.5 Million USD | -6.86% |
| 1998 Q2 | 10.2 Million USD | 67.21% |
| 1998 Q1 | 6.1 Million USD | 8.93% |
| 1997 Q1 | 3.3 Million USD | 10.0% |
| 1997 FY | 12.7 Million USD | 9.48% |
| 1997 Q4 | 5.6 Million USD | -6.67% |
| 1997 Q3 | 6 Million USD | 50.0% |
| 1997 Q2 | 4 Million USD | 21.21% |
| 1996 Q1 | 2.8 Million USD | -6.67% |
| 1996 Q2 | 3.5 Million USD | 25.0% |
| 1996 Q3 | 2.2 Million USD | -37.14% |
| 1996 Q4 | 3 Million USD | 36.36% |
| 1996 FY | 11.6 Million USD | 30.34% |
| 1995 Q4 | 3 Million USD | 20.0% |
| 1995 Q1 | 2.1 Million USD | 5.0% |
| 1995 FY | 8.9 Million USD | 25.35% |
| 1995 Q3 | 2.5 Million USD | -16.67% |
| 1995 Q2 | 3 Million USD | 42.86% |
| 1994 Q4 | 2 Million USD | 5.26% |
| 1994 FY | 7.1 Million USD | 24.56% |
| 1994 Q1 | 1.7 Million USD | -15.0% |
| 1994 Q2 | 1.6 Million USD | -5.88% |
| 1994 Q3 | 1.9 Million USD | 18.75% |
| 1993 FY | 5.7 Million USD | 0.0% |
| 1993 Q1 | 1.3 Million USD | 0.0% |
| 1993 Q4 | 2 Million USD | 5.26% |
| 1993 Q2 | 1.6 Million USD | 23.08% |
| 1993 Q3 | 1.9 Million USD | 18.75% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -7415.574% |
| Cerus Corporation | 143.15 Million USD | -489.255% |
| OrthoPediatrics Corp. | 137.01 Million USD | -515.643% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -7325.033% |
| Talis Biomedical Corporation | 67.18 Million USD | -1155.541% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -3281.496% |
| Inogen, Inc. | 236.08 Million USD | -257.307% |
| Spectral AI, Inc. | 20.86 Million USD | -3943.079% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1406.416% |
| CVRx, Inc. | 76.14 Million USD | -1007.862% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -23810.118% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -6654.328% |
| Orthofix Medical Inc. | 667.42 Million USD | -26.388% |
| Venus Concept Inc. | 80.47 Million USD | -948.198% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -1390.947% |
| Bioventus Inc. | 409.91 Million USD | -105.785% |
| BrainsWay Ltd. | 28.01 Million USD | -2910.736% |
| Envoy Medical, Inc. | 17.89 Million USD | -4613.085% |
| electroCore, Inc. | 32.03 Million USD | -2533.536% |
| IceCure Medical Ltd | 16.87 Million USD | -4898.507% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -1888.0% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -4683.909% |
| MaxCyte, Inc. | 84.84 Million USD | -894.222% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -6696.357% |
| Nexalin Technology, Inc. | 5.78 Million USD | -14490.833% |
| PAVmed Inc | 64.82 Million USD | -1201.229% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -1551.49% |
| RxSight, Inc. | 103.85 Million USD | -712.275% |
| Sight Sciences, Inc. | 126.44 Million USD | -567.105% |
| SI-BONE, Inc. | 156.35 Million USD | -439.522% |
| TELA Bio, Inc. | 84.18 Million USD | -901.993% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -1104.105% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -314.795% |
| 908 Devices Inc. | 68.08 Million USD | -1139.054% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -74.432% |
| Nemaura Medical Inc. | 7.13 Million USD | -11716.379% |
| NeuroPace, Inc. | 75.29 Million USD | -1020.309% |
| LENSAR, Inc. | 33.33 Million USD | -2430.442% |
| Apyx Medical Corporation | 51.01 Million USD | -1553.432% |
| Cutera, Inc. | 197.72 Million USD | -326.629% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -3304.011% |
| BioSig Technologies, Inc. | 28.53 Million USD | -2856.705% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -340.553% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -2239.29% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | -0.856% |
| Axonics, Inc. | 270.2 Million USD | -212.192% |
| Outset Medical, Inc. | 198.77 Million USD | -324.384% |
| IRIDEX Corporation | 31.81 Million USD | -2551.499% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -368.068% |
| IRadimed Corporation | 30.12 Million USD | -2700.363% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -9786.873% |
| INVO Bioscience, Inc. | 7.85 Million USD | -10641.329% |
| Telesis Bio, Inc. | 63.48 Million USD | -1228.652% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -756.803% |
| Varex Imaging Corporation | 224.8 Million USD | -275.244% |
| Quipt Home Medical Corp. | 148.66 Million USD | -467.408% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7095.667% |
| Pulmonx Corporation | 112.68 Million USD | -648.576% |
| Dynatronics Corporation | 9.9 Million USD | -8413.785% |
| Modular Medical, Inc. | 17.52 Million USD | -4712.3% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -4078.669% |
| Semler Scientific, Inc. | 38.94 Million USD | -2066.054% |
| InMode Ltd. | 215.68 Million USD | -291.111% |
| Bruker Corporation | 1.07 Billion USD | 21.632% |
| Cytosorbents Corporation | 48.33 Million USD | -1645.145% |
| DexCom, Inc. | 1.69 Billion USD | 50.121% |
| Align Technology, Inc. | 2.07 Billion USD | 59.383% |
| Viveve Medical, Inc. | 22.17 Million USD | -3704.393% |
| ZimVie Inc. | 275.12 Million USD | -206.604% |
| Movano Inc. | 29.69 Million USD | -2741.186% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -514.513% |
| Nexalin Technology, Inc. | 5.78 Million USD | -14490.833% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -23810.118% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -40.376% |
| Profound Medical Corp. | 33.6 Million USD | -2410.325% |
| Insulet Corporation | 939.9 Million USD | 10.251% |
| enVVeno Medical Corporation | 25.23 Million USD | -3242.373% |
| Surmodics, Inc. | 98.69 Million USD | -754.685% |
| iCAD, Inc. | 22.22 Million USD | -3695.492% |
| Nuwellis, Inc. | 22.61 Million USD | -3630.367% |
| Biotricity, Inc. | 17.18 Million USD | -4808.758% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -89.183% |
| Aethlon Medical, Inc. | 12.27 Million USD | -6770.676% |
| InspireMD, Inc. | 22.95 Million USD | -3575.59% |
| PAVmed Inc. | 64.82 Million USD | -1201.229% |
| BIOLASE, Inc. | 34.66 Million USD | -2333.709% |
| Beyond Air, Inc. | 61.7 Million USD | -1267.177% |
| FONAR Corporation | 28.6 Million USD | -2848.986% |
| AxoGen, Inc. | 149.33 Million USD | -464.866% |
| Vivani Medical, Inc. | 26.96 Million USD | -3028.307% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -376.333% |
| Inari Medical, Inc. | 448.59 Million USD | -88.042% |
| UFP Technologies, Inc. | 58.08 Million USD | -1352.165% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -17018.844% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -13250.893% |
| Tenon Medical, Inc. | 16.96 Million USD | -4871.405% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -11310.091% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -1812.684% |
| AdaptHealth Corp. | 1.07 Billion USD | 21.746% |
| Sintx Technologies, Inc. | 15.2 Million USD | -5449.293% |
| NanoVibronix, Inc. | 4.97 Million USD | -16862.558% |
| Quanterix Corporation | 118.1 Million USD | -614.266% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7095.667% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -5740.936% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -114.826% |
| TransMedics Group, Inc. | 182.82 Million USD | -361.409% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -2905.694% |
| NeuroMetrix, Inc. | 11.09 Million USD | -7500.261% |
| Hyperfine, Inc. | 52.87 Million USD | -1495.453% |
| Establishment Labs Holdings Inc. | 172 Million USD | -390.426% |
| Biomerica, Inc. | 6.97 Million USD | -11988.679% |
| Bone Biologics Corporation | 9.42 Million USD | -8846.976% |
| AVITA Medical, Inc. | 80.77 Million USD | -944.264% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -8080.878% |
| Silk Road Medical, Inc | 186.35 Million USD | -352.652% |